Renalogic is the NYLHCAS's recommended Chronic Kidney Disease (CKD) & Dialysis Benefits provider. They are the market leader helping self-funded plans and health plan members manage the financial and human costs of CKD and dialysis.
Please click here for details on this benefit - which does include a complimentary cost analysis for member funds
CKD Facts:
- 1 in 7 U.S. adults (37M people) have CKD – but 90% don’t know they have it.
- The top CKD risk factors include diabetes, cardiovascular disease, obesity, high blood pressure, high cholesterol and more.
- CKD currently is the #10 leading cause of death in the U.S. and is projected to be #5 by 2040.
- The average commercial dialysis costs are 700% more than Medicare – $300,000 annually per health plan member on dialysis.
How We Help:
- Identify hidden CKD risks and what’s driving increased spend through algorithmic claims analysis.
- Prevent CKD progression and improve health plan member health with early, specialized clinical interventions.
- Forestall end-stage renal disease (ESRD) and avoid emergent dialysis starts with care management and navigation services for late-stage CKD members.
- Reduce high-cost dialysis claims with proprietary repricing methodology.
Our Results:
- 230% more effective at finding undiagnosed CKD.
- 30% reduction in emergent dialysis starts.
- 50-80% reduction in dialysis costs vs. contracted rates
Self-Funded Plans
Health Plan Members
Learn more: renalogic.com
Contact Us:
Tara Metzner
Vice President – Key Accounts
Taft Hartley Plans & TPA Partnerships
M: 503.886.9640
M: 208.627.8729
E: tmetzner@renalogic.com
LinkedIn: https://www.linkedin.com/in/tara-m-48991956/
Schedule a meeting: https://calendly.com/tmetzner-1/30min

Josh Peters
Client Services Manager
jpeters@renalogic.com
208-920-1217